Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3121–3144 of 145,521 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Duchenne Muscular Dystrophy
Interventions: Ataluren; Drug
Lead sponsor: PTC Therapeutics; Industry
Eligibility: Male only
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2026
U.S. locations: 29
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 25 more

Conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1
Interventions: CGM; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Columbia, Maryland

Conditions: Danon Disease
Interventions: No intervention; Other
Lead sponsor: Rocket Pharmaceuticals Inc.; Industry
Eligibility: 8 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 9
States / cities: Phoenix, Arizona • La Jolla, California • Aurora, Colorado + 6 more

Conditions: Alzheimer Disease, White Matter Hyperintensities, Dementia, Aging
Interventions: Florbetaben F18, Transcranial Doppler; Radiation · Procedure
Lead sponsor: Columbia University; Other
Eligibility: 60 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Influenza a, Influenza B, RSV, COVID 19
Interventions: LIAISON NES FLU A/B, RSV & COVID-19; Diagnostic Test
Lead sponsor: DiaSorin Molecular LLC; Industry
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Henderson, Nevada • Pittsburgh, Pennsylvania • McAllen, Texas

Conditions: Tooth Pain
Interventions: Not listed
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Albany, New York

Conditions: Endothelial Function, Diabetes Mellitus, Hypertension
Interventions: carvedilol, metoprolol extended release; Drug
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Fall Patients, Delirium, Quality of Life, Functional Status
Interventions: Geriatric Screening tools; Other
Lead sponsor: Ohio State University; Other
Eligibility: 65 Years and older
Enrollment: 373 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Renal Cell Carcinoma, Kidney Cancer, Kidney Neoplasm, Renal Carcinoma
Interventions: Casdatifan, Zimberelimab; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Pregnancy Related, Narcolepsy
Interventions: Pitolisant, Comparator Products; Drug
Lead sponsor: Harmony Biosciences Management, Inc.; Industry
Eligibility: Female only
Enrollment: 1,329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Morrisville, North Carolina

Conditions: PAD - Peripheral Arterial Disease, Vascular Diseases, Wounds
Interventions: PIUR tUS Imaging System; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Sleep, Anxiety, Depression, Pain
Interventions: fsCBD Cannabidiol, Placebo, bsCBD Cannabidiol; Drug
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 25 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Alzheimer Disease, Healthy Aging
Interventions: Usability evaluation of BrightGo computerized device for cognitive therapy of individuals with early Alzheimer's Disease; Device
Lead sponsor: Bright Cloud International Corp; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: North Brunswick, New Jersey

Conditions: Nicotine Dependence, ADHD
Interventions: Very low nicotine content cigarettes, Conventional nicotine content cigarettes; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Durham, North Carolina • Pittsburgh, Pennsylvania

Conditions: Steatohepatitis, Nonalcoholic, Hemosiderosis, Overweight Adolescents, Obesity, Childhood, Liver Steatosis
Interventions: Not listed
Lead sponsor: The Geneva Foundation; Other
Eligibility: 10 Years to 17 Years
Enrollment: 150 participants
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: HIV Infections, Smoking, Smoking Cessation
Interventions: Wellness Intervention for Smokers with HIV; Behavioral
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: adjunctive treatment with buspirone, placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Respiratory Syncytial Virus (RSV)
Interventions: RSV-F Vaccine, Phosphate Buffer Placebo; Biological
Lead sponsor: Novavax; Industry
Eligibility: 60 Years and older
Enrollment: 1,330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 10
States / cities: Redding, California • Stockbridge, Georgia • Lenexa, Kansas + 7 more

Conditions: Breast Cancer
Interventions: Polygenic Risk Score; Genetic
Lead sponsor: Mayo Clinic; Other
Eligibility: 35 Years to 75 Years · Female only
Enrollment: 737 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2029
U.S. locations: 5
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Evanston, Illinois + 2 more

Conditions: Renal Cell Carcinoma
Interventions: Optison; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Asthma
Interventions: Montelukast 10 mg orally, Placebo; Drug · Other
Lead sponsor: Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.; Other
Eligibility: 65 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Bryn Mawr, Pennsylvania

Conditions: Alzheimers Disease
Interventions: Gantenerumab, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 60 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 32
States / cities: Phoenix, Arizona • Sun City, Arizona • Tucson, Arizona + 28 more

Conditions: Bone Disease, Metabolic, Osteopenia, Osteoporosis, Post-Traumatic
Interventions: Pulsing electromagnetic field (PEMF); Device
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Type1 Diabetes
Interventions: HCL, verapamil 120mg tablet, non-HCL, placebo; Device · Drug
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 7 Years to 17 Years
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 6
States / cities: Palo Alto, California • Aurora, Colorado • New Haven, Connecticut + 3 more

Search by objective public record fields.

Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)

Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes

Danon Disease Natural History Study

Brain Vascular Disease in Aging and Dementia

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

Cohort Comparison of Dental Nerve Block With Other Forms of Analgesia in Alleviating the Pain of Toothache

Coreg CR, Blood Vessel Stiffness and Blood Vessel Function

Implementation of Multidisciplinary Assessments for Geriatric Patients in an ED Observation Unit

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

WAKIX® (Pitolisant) Pregnancy Registry

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies

Cannabis for Palliative Care in Cancer

Telerehabilitation Alzheimer's Disease Usability (TADU)

Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients

Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV

Serotonin 1A Agonists and Cognition in Schizophrenia

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study

Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation

Asthma in the Elderly: The Effect of Montelukast

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Electromagnetic Treatment For Bone Loss After Forearm Fracture

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes